Uncovering the Potential of Phosphatidylinositol 3-Kinase Inhibitors in Cutaneous T-Cell Lymphoma: Insights from High-Throughput In Vitro Screenings

J Invest Dermatol. 2022 Jan;142(1):254-257. doi: 10.1016/j.jid.2021.04.035. Epub 2021 Jul 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Skin Neoplasms* / drug therapy

Substances

  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors